Prevalence and trends of advanced HIV disease among antiretroviral therapy-naïve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis
- PMID: 37608300
- PMCID: PMC10464046
- DOI: 10.1186/s12879-023-08521-4
Prevalence and trends of advanced HIV disease among antiretroviral therapy-naïve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis
Abstract
Background: Despite the significant progress made in South Africa in getting millions of individuals living with HIV into care, many patients still present or re-enter care with Advanced HIV Disease (AHD). We aimed to estimate the prevalence of AHD among ART-naive and ART-experienced patients in South Africa using studies published between January 2010 and May 2022.
Methods: We searched for relevant data on PubMed, CINAHL, Scopus and other sources, with a geographical filters limited to South Africa, up to May 31, 2022. Two reviewers conducted all screening, eligibility assessment, data extraction, and critical appraisal. We synthesized the data using the inverse-variance heterogeneity model and Freeman-Tukey transformation. We assessed heterogeneity using the I2 statistic and publication bias using the Egger and Begg's test.
Results: We identified 2,496 records, of which 53 met the eligibility criteria, involving 11,545,460 individuals. The pooled prevalence of AHD among ART-naive and ART-experienced patients was 43.45% (95% CI 40.1-46.8%, n = 53 studies) and 58.6% (95% CI 55.7 to 61.5%, n = 2) respectively. The time trend analysis showed a decline of 2% in the prevalence of AHD among ART-naive patients per year. However, given the high heterogeneity between studies, the pooled prevalence should be interpreted with caution.
Conclusion: Despite HIV's evolution to a chronic disease, our findings show that the burden of AHD remains high among both ART-naive and ART-experienced patients in South Africa. This emphasizes the importance of regular measurement of CD4 cell count as an essential component of HIV care. In addition, providing innovative adherence support and interventions to retain ART patients in effective care is a crucial priority for those on ART.
Keywords: ART-experienced; ART-naïve; Advanced HIV disease; Burden; South Africa.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Persistent advanced HIV disease in rural KwaZulu-Natal, South Africa: Trends, characteristics, and the urgent need for targeted interventions.PLoS One. 2025 Feb 18;20(2):e0317674. doi: 10.1371/journal.pone.0317674. eCollection 2025. PLoS One. 2025. PMID: 39965033 Free PMC article.
-
Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis.BMJ Glob Health. 2025 Apr 9;10(4):e016631. doi: 10.1136/bmjgh-2024-016631. BMJ Glob Health. 2025. PMID: 40204463 Free PMC article.
-
Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model.AIDS. 2023 Mar 1;37(3):513-522. doi: 10.1097/QAD.0000000000003442. Epub 2022 Nov 24. AIDS. 2023. PMID: 36695361 Free PMC article.
-
Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.AIDS Behav. 2020 Jun;24(6):1727-1742. doi: 10.1007/s10461-019-02716-0. AIDS Behav. 2020. PMID: 31673913 Free PMC article.
-
The prevalence of anemia among human immunodeficiency virus-infected individuals in East Africa: A systematic review and meta-analysis.Medicine (Baltimore). 2023 May 19;102(20):e33810. doi: 10.1097/MD.0000000000033810. Medicine (Baltimore). 2023. PMID: 37335739 Free PMC article.
Cited by
-
Host-Directed Therapies Based on Protease Inhibitors to Control Mycobacterium tuberculosis and HIV Coinfection.Microorganisms. 2025 Apr 30;13(5):1040. doi: 10.3390/microorganisms13051040. Microorganisms. 2025. PMID: 40431213 Free PMC article. Review.
-
Hemophagocytic Lymphohistiocytosis Secondary to Miliary Tuberculosis in a Resource-Limited Setting: A Case Report.Cureus. 2024 Nov 15;16(11):e73733. doi: 10.7759/cureus.73733. eCollection 2024 Nov. Cureus. 2024. PMID: 39677074 Free PMC article.
-
Retrospective analysis of CD4 count trends in South Africa.South Afr J HIV Med. 2024 Dec 19;25(1):1651. doi: 10.4102/sajhivmed.v25i1.1651. eCollection 2024. South Afr J HIV Med. 2024. PMID: 39822279 Free PMC article.
-
Treatment of Advanced HIV in the Modern Era.Drugs. 2025 Jul;85(7):883-909. doi: 10.1007/s40265-025-02181-1. Epub 2025 May 12. Drugs. 2025. PMID: 40354016 Free PMC article. Review.
-
Trends in prevalent TB among persons enrolling for HIV care before and after 'Test and Treat' across East-Africa.IJTLD Open. 2025 Jun 13;2(6):359-365. doi: 10.5588/ijtldopen.24.0687. eCollection 2025 Jun. IJTLD Open. 2025. PMID: 40530380 Free PMC article.
References
-
- HIV/AIDS JUNPo. Confronting inequalities: lessons for pandemic responses from 40 years of AIDS. Report No: UNAIDS/JC3020E Global AIDS update Geneva. Joint United Nations Programme on HIV/AIDS (UNAIDS; 2021.
-
- Organization WH. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous